GDRX

4.50

0.44% -0.02

After Hours: 4.41 -0.09 -2.00%

Goodrx Holdings Inc (GDRX)

Overview News Price History Option Chain Financials Why GDRX Down? Discussions Forecast

Goodrx Holdings Inc stock is traded at $4.50, with a volume of 1.80M. It is down -0.44% in the last 24 hours and down -9.64% over the past month.

Previous Close:

$4.52

Open:

$4.51

24h Volume:

1.80M

Relative Volume:

1.28

Market Cap:

$1.73B

Revenue:

$775.09M

Net Income/Loss:

$-58.68M

P/E Ratio:

-33.94

EPS:

-0.1326

Net Cash Flow:

$64.06M

1W Performance:

-3.02%

1M Performance:

-9.64%

6M Performance:

-34.31%

1Y Performance:

-36.62%

1-Day Range:

$4.43

$4.75

1-Week Range:

$4.43

$4.79

52-Week Range:

$4.09

$9.2599

Goodrx Holdings Inc Stock (GDRX) Company Profile

Name

Goodrx Holdings Inc

Sector

Healthcare (1166)

Industry

Health Information Services (57)

Phone

(855) 268-2822

Address

2701 OLYMPIC BOULEVARD, SANTA MONICA

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

GDRX's Discussions on Twitter

Compare GDRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GDRX Goodrx Holdings Inc	4.50	1.73B	775.09M	-58.68M	64.06M	-0.1326
VEEV Veeva Systems Inc	234.21	38.81B	2.75B	714.14M	1.09B	4.33
SOLV Solventum Corp	74.75	12.84B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	58.51	11.36B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	47.83	10.16B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	86.96	7.54B	1.15B	96.70M	-161.99M	1.09

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-04-24	Initiated	Mizuho	Neutral
Aug-09-24	Upgrade	Raymond James	Outperform → Strong Buy
May-23-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
May-16-24	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-01-24	Upgrade	JP Morgan	Neutral → Overweight
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-02-24	Downgrade	BofA Securities	Buy → Underperform
Aug-10-23	Upgrade	DA Davidson	Neutral → Buy
Jul-31-23	Upgrade	TD Cowen	Market Perform → Outperform
Dec-01-22	Initiated	Citigroup	Buy
Nov-04-22	Upgrade	JP Morgan	Underweight → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-12-22	Initiated	DA Davidson	Neutral
Jun-10-22	Downgrade	Goldman	Buy → Neutral
Jun-06-22	Resumed	BofA Securities	Buy
Jun-01-22	Downgrade	Robert W. Baird	Outperform → Neutral
May-10-22	Downgrade	Evercore ISI	Outperform → In-line
May-10-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
May-10-22	Downgrade	Raymond James	Outperform → Mkt Perform
May-10-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-11-22	Initiated	Wells Fargo	Equal Weight
Apr-07-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Neutral
Mar-15-22	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-01-22	Reiterated	Barclays	Overweight
Mar-01-22	Reiterated	BofA Securities	Neutral
Mar-01-22	Downgrade	Cowen	Outperform → Market Perform
Mar-01-22	Downgrade	Credit Suisse	Outperform → Neutral
Mar-01-22	Reiterated	Evercore ISI	Outperform
Mar-01-22	Reiterated	Goldman	Buy
Mar-01-22	Reiterated	JP Morgan	Underweight
Mar-01-22	Reiterated	RBC Capital Mkts	Outperform
Mar-01-22	Reiterated	SVB Leerink	Outperform
Jan-07-22	Initiated	Goldman	Buy
Dec-21-21	Initiated	Stephens	Overweight
Dec-02-21	Initiated	Jefferies	Buy
Aug-31-21	Upgrade	Barclays	Equal Weight → Overweight
Aug-13-21	Upgrade	Raymond James	Mkt Perform → Outperform
May-28-21	Initiated	Robert W. Baird	Neutral
Apr-06-21	Resumed	Evercore ISI	Outperform
Jan-25-21	Initiated	Guggenheim	Buy
Nov-19-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Nov-18-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-19-20	Initiated	Barclays	Equal Weight
Oct-19-20	Initiated	BofA Securities	Neutral
Oct-19-20	Initiated	Citigroup	Buy
Oct-19-20	Initiated	Cowen	Outperform
Oct-19-20	Initiated	Credit Suisse	Outperform
Oct-19-20	Initiated	Deutsche Bank	Hold
Oct-19-20	Initiated	Goldman	Neutral
Oct-19-20	Initiated	JP Morgan	Neutral
Oct-19-20	Initiated	Morgan Stanley	Overweight
Oct-19-20	Initiated	RBC Capital Mkts	Sector Perform
Oct-19-20	Initiated	SVB Leerink	Outperform
Oct-19-20	Initiated	UBS	Buy

View All

Goodrx Holdings Inc Stock (GDRX) Latest News

Mar 27, 2025

Levi & Korsinsky Notifies GoodRx Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineGDRX - ACCESS Newswire

Mar 27, 2025

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital - Yahoo Finance

Mar 27, 2025

Mar 25, 2025

Do Fundamentals Have Any Role To Play In Driving GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Stock Up Recently? - Simply Wall St

Mar 25, 2025

Mar 24, 2025

GoodRx: Great Value For Patient Investors (Upgrade) (NASDAQ:GDRX) - Seeking Alpha

Mar 24, 2025

Mar 17, 2025

PBMs Hit With Antitrust Suit Over GoodRx Generics Program - Law360

Mar 17, 2025

GoodRx Strengthens Leadership: $100M Revenue Leader Takes President Role - StockTitan

Mar 17, 2025

Mar 13, 2025

GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by US Bancorp DE - Defense World

Mar 13, 2025

Mar 10, 2025